na INLIS000000000017637 20221206094825 221206 | | | 0010-0721002169 ARTVET2269 ARTVET2269 Vaccine Efficacy on the Novel Reassortant H9N2 Virus in Indonesia / Dharmayanti, Ni Luh Putu Indi ; Indriani, Risa Nurjanah, Diana (Balai Besar Penelitian Veteriner) Vaccines 2020 Vol. 8, 449. 2020 Vaccination is one of the leading methods of controlling the spread of the Avian Influenza (AI) viruses in Indonesia. The variety of circulating viruses and their ability to mutate must be followed by updating the vaccine master seed used in the field. In this study, we identified the reassortant H9N2 viruses in chicken farms that showed significant problems in decreased egg production with high mortality. The reassortant H9N2 viruses derived the PB2 gene from the H5N1 virus. The pathogenicity test results of the reassortant virus showed various clinical signs of illness, a high mortality rate (10%), and decreased egg production down to 63.12% at two weeks post-infection. In a vaccine ecacy test, the vaccinated groups showed minimally decreased egg production that started to increase to more than 80% at 4–7 weeks post-challenge. Our study showed that inactivated bivalent and monovalent reassortant H9N2 vaccines can induce antibody response, reducing the mortality and virus shedding caused by reassortant H9N2 virus infection. The reassortant H9N2 virus is a threat that requires vigilance in poultry farms and the industry. The vaccines used in this study can be one of the options for control or prevention measures on farms infected with the reassortant H9N2 viruses. avian influenza; reassortant; inactivated; vaccine; pathogenicity; efficacy Indriani, Risa Nurjanah, Diana (Balai Besar Penelitian Veteriner) doi:10.3390/vaccines8030449 ARTVET2269